Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus
NCT: NCT06587438 · ACTIVE_NOT_RECRUITING
Brief Summary
The clinical value of CGM for diabetic patients undergoing insulin therapy has been widely recognized, but the evidence-based support for its use in non-insulin-treated type 2 diabetic patients remains insufficient. The primary objective of this study is to evaluate the effect of real-time continuous glucose monitoring (CGM) compared with self-monitoring of blood glucose on glycemic control in adults with non-insulin treated type 2 diabetes.
Frequently Asked Questions
What is Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus?
Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus is a clinical trial registered under NCT06587438. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06587438?
The current status of NCT06587438 (Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus) is: ACTIVE_NOT_RECRUITING.
When did Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus start?
Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus started on 2025-01-17.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.